|
|
Building Resources to Assess Impaired Neurocognition in Children with HIV in Low- and Middle-Income Countries (BRAIN Child in LMICs) |
| 3R21TW012104-02S1 |
|
FIC |
2022 |
|
|
Modulatory Effects of the Functional Gut Microbiome in Relation to Cassava Associated Motor and Neurocognitive Deficits |
| 5K01TW011772-02 |
|
FIC |
2022 |
|
|
Building Resources to Assess Impaired Neurocognition in Children with HIV in Low- and Middle-Income Countries (BRAIN Child in LMICs) |
| 5R21TW012104-02 |
|
FIC |
2022 |
|
|
Biomarkers for Detection and Prediction of Chemotherapy-Related Cognitive Impairment |
| 3P30CA014520-48S5 |
|
NCI |
2022 |
|
|
Psychosocial Risk in Young Survivors of Early Onset Pediatric Cancer: The Role of Physical and Neurocognitive Late Effects |
| 3R01CA248103-02S1 |
|
NCI |
2022 |
|
|
Psychosocial Risk in Young Survivors of Early Onset Pediatric Cancer: The Role of Physical and Neurocognitive Late Effects |
| 3R01CA248103-02S2 |
|
NCI |
2022 |
|
|
Integrative Molecular Epidemiology of Neurocognitive Outcomes in Acute Lymphoblastic Leukemia |
| 5K07CA218362-05 |
|
NCI |
2022 |
|
|
Very-long Term Neurocognitive Outcomes in Breast Cancer Survivors |
| 5R01CA172145-08 |
|
NCI |
2022 |
|
|
Predicting Long-Term Chemotherapy-Related Cognitive Impairment |
| 5R01CA226080-04 |
|
NCI |
2022 |
|
|
Psychosocial Risk in Young Survivors of Early Onset Pediatric Cancer: The Role of Physical and Neurocognitive Late Effects |
| 5R01CA248103-02 |
|
NCI |
2022 |
